Rani Therapeutics suspends two development programs, closes one and lays off one in four employees
Rani Therapeutics is working on developing a new dosage form where even drugs with large molecules can be delivered through a tablet; or a so-called ”robot pill”.
Rani Therapeutics has run into money problems, and therefore the company is focusing its business – and this means layoffs and a suspension of two development programs and a complete shutdown of a third, the company writes this in a stock exchange announcement.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
